The Misleading Marketing of “Low-T” Drugs

A conversation with Adriane Fugh-Berman, MD, Associate Professor at Georgetown University Medical Center and Director of PharmedOut.

Venkat Gullapalli, MD, and Mark Goldstone: Benchmark Your Marketing Effectiveness Using Medikly’s Physician Value...

In this 3.5-minute audio snippet, Venkat Gullapalli, MD, and Mark Goldstone, Medikly Co-CEOs, talk about The Physician Value Index and how it can be used to provide marketing effectiveness benchmarks that are specific to your organization.

Ryan McGuire: Pharma’s Mobile Development Challenges

In this 4-minute audio snippet, Ryan McGuire, Research Team Leader at Cutting Edge Information, talks about some of the challenges faced by small and large pharmaceutical companies in launching mobile apps including picking the right agency, determining at what point in a drug's lifecycle to begin the process, and how to coordinate a true global launch of a mobile campaign.

Lea Katsanis: Benefits & Risks of Rx Brand Personality

In this 2.5-minute audio snippet, Lea Katsanis, PhD, Marketing Professor at Concordia University's John Molson School of Business, talks about Rx brand personalities as perceived by consumers and how pharmaceutical marketers can use or abuse how consumers perceive their brands' human characteristics.

Reports of the Demise of Medical Journal Ads Have Been Greatly Exaggerated

In this 2.5-minute audio snippet, Pharmaguy presents data from Kantar Media that shows that the death of professional print pharma advertising has been greatly exaggerated. He gets into which companies and drugs have spent the most on journal advertising and summarizes a study of physician attitudes regarding these ads.

Pharmaguy™ Interviews John LaMattina: Devalued and Distrusted

In this 4-minute snippet, recorded 28 May 2013, John LaMattina, former Pfizer president of Research and Development, reveals what inspired him to write the book "Devalued and Distrusted: Can the Pharmaceutical Industry restore Its Broken Image?"

Jessica Federer: Empower Pharma Employees to Advance Digitalization in Your Organization

In this 1-minute audio snippet, Jessica Federer, Head of Digital Development at Bayer, talks about how Bayer employees its employees to advance the digitalization of the organization.

Jerry Matczak: Open Innovation Engages Patients in Pharma R&D

In this 4-minute audio snippet, Jerry Matczak, Community Manager for the Lilly Clinical Open Innovation Team, explains how the Internet, transparency, sharing innovation, and engaging patients in online communities can change how pharmaceutical companies do research.

Jeff Tangney: How Doximity Creates Online Physician “Niche” Communities & Discussions

In this 2-minute audio snippet, Jeff Tangney, CEO & Founder, Doximity, talks about online physician chat rooms and how 'niche' communities are created around specific content posted to the site.

The Potential Impact of IoT Technology on Health Outcomes and Adherence

While attending an eyeforpharma Philadelphia conference, Pharmaguy interviewed Jeff Usewick, Director for Healthcare Business Development at SoftServe, about how the drug industry should focus on using Internet of Things technology to improve health outcomes. Better adherence and profits will then follow.